Professor Clemens-Martin Wendtner, MD

Specialist in internal medicine, haematology and internal oncology with additional training in haemostaseology and palliative medicine

Prof. Wendtner studied medicine from 1985 to 1992 at the University of Münster, Emory University in Atlanta (USA), the University of Florida in Gainesville (USA) and the National Institutes of Health (NIH/NCI) in Bethesda (USA). In 1993, he completed his experimental doctoral thesis on the significance of MYC, TdT and ETS1 in malignant haematopoiesis at the University of Münster under Prof. Dr. van de Loo. After working as an intern at the Medical Clinic of Ludwig Maximilian University (LMU) in Munich (Prof. Scriba), Prof. Wendtner received his full medical licence in 1994.

This was followed by two years of postdoctoral research at the Max Planck Institute for Biochemistry in Martinsried (Prof. Dr. Winnacker) and at the National Institutes of Health (NIH/NHLBI) in Prof. Kotin's research group. In 1995, Prof. Wendtner began his training as an internist at the Medical Clinic of Ludwig Maximilian University (LMU) under Prof. Scriba and continued this training in 1998 at the III. Medical Clinic of the Großhadern Clinic of LMU under Prof. Hiddemann. In 1999, Prof. Wendtner was recognised as a specialist in internal medicine, and in 2000, he was awarded the title of specialist in haematology and internal oncology by the Bavarian State Medical Association. Two years later, he habilitated on the significance of recombinant EBV and AAV vectors for the gene transfer of costimulatory molecules in CLL and was appointed private lecturer at Ludwig Maximilian University in Munich in 2002.

In 2003, he moved with Prof. Hallek to the University of Cologne, where he was appointed senior physician at Clinic I for Internal Medicine in the same year. In 2004, he was appointed tenured university professor (C3) for haematology and oncology at the University of Cologne. During this time, he was accepted into the Strategy Commission and later appointed Scientific Secretary of the German CLL Study Group (DCLLSG). During his time as senior physician, Prof. Wendtner acquired extensive knowledge in the field of haematology, but also gained profound experience in the field of solid neoplasms as head of the Oncology Day Clinic and head of an EORTC centre. He also trained in clinical infectiology under the supervision of Prof. Fätkenheuer. Prof. Wendtner obtained additional qualifications in palliative medicine in 2007 and haemostaseology in 2011.

In 2011, Prof. Wendtner returned to Munich and was appointed Chief Physician at the Clinic for Haematology, Oncology, Immunology, Palliative Medicine, Infectious Diseases and Tropical Medicine at Munich Clinic, an academic teaching hospital affiliated with Ludwig Maximilian University. During this time, he established the Department of Allogeneic Stem Cell Transplantation in 2012. In January 2020, he treated the first patients in Germany during the COVID-19 pandemic and was subsequently appointed to the ad hoc advisory board of the National Academy of Sciences (Leopoldina). He was also appointed a member of the Covid-19 expert panel of the Federal Ministry of Health (BMG), the Bavarian State Ministry of Health and Care (StMGP) and the Bavarian State Chancellery. In 2022, he was awarded the Bavarian Order of Merit by Bavarian Minister-President Dr. Markus Söder for his services to the Free State of Bavaria in the context of the Covid-19 pandemic.

Since 2011, Prof. Wendtner has been an examiner for the Department of Internal Medicine and Haematology/Oncology at the Bavarian State Medical Association (BLÄK). Since 2015, he has been advising the Joint Federal Committee (G-BA) as an expert on the benefit assessment of medicinal products. Since 2017, Prof. Wendtner has been a member of the Scientific Ethics Commission of Ludwig Maximilian University (LMU) and was elected deputy chair of this committee at the LMU Faculty of Medicine in 2019. In 2023, he was appointed adjunct professor of internal medicine at LMU.

In 2023, Prof. Wendtner took over as medical partner of Radiologie München and head of oncology at the Interdisciplinary Oncology Centre (IOZ), which was founded in 2012 as an offshoot of the joint practice for haematology and internal oncology of Prof. Emmerich and Prof. Maubach and expanded to include further oncological specialisations in the fields of dermatology, gynaecology, urology and complementary medicine.

In addition to his work at the IOZ, Professor Wendtner teaches at Ludwig Maximilian University (LMU) and serves as a senior consultant for haematology/oncology and infectiology at LMU.

For scientific publications, see PubMed https://pubmed.ncbi.nlm.nih.gov/?term=Wendtner+C&sort=date